Switch theme
Sign up to access all valuation multiples
Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.
2005
217
LTM Revenue $25.8M
LTM EBITDA $2.1M
$122M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Bactiguard has a last 12-month revenue of $25.8M and a last 12-month EBITDA of $2.1M.
In the most recent fiscal year, Bactiguard achieved revenue of $26.0M and an EBITDA of $2.6M.
Bactiguard expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Bactiguard valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $20.3M | $26.0M | XXX | XXX | XXX |
| Gross Profit | $17.9M | $13.9M | XXX | XXX | XXX |
| Gross Margin | 88% | 53% | XXX | XXX | XXX |
| EBITDA | -$7.7M | $2.6M | XXX | XXX | XXX |
| EBITDA Margin | -38% | 10% | XXX | XXX | XXX |
| Net Profit | -$5.3M | -$13.7M | XXX | XXX | XXX |
| Net Margin | -26% | -53% | XXX | XXX | XXX |
| Net Debt | n/a | $5.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Bactiguard's stock price is SEK 32 (or $3).
Bactiguard has current market cap of SEK 1.1B (or $111M), and EV of SEK 1.2B (or $122M).
See Bactiguard trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $122M | $111M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Bactiguard has market cap of $111M and EV of $122M.
Bactiguard's trades at 4.7x LTM EV/Revenue multiple, and 58.8x LTM EBITDA.
Analysts estimate Bactiguard's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Bactiguard and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $122M | XXX | XXX | XXX |
| EV/Revenue | 4.7x | XXX | XXX | XXX |
| EV/EBITDA | 47.5x | XXX | XXX | XXX |
| P/E | -37.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 120.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBactiguard's NTM/LTM revenue growth is 2%
Bactiguard's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Bactiguard's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Bactiguard's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Bactiguard and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 28% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -133% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 12% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 97% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bactiguard acquired XXX companies to date.
Last acquisition by Bactiguard was XXXXXXXX, XXXXX XXXXX XXXXXX . Bactiguard acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Bactiguard founded? | Bactiguard was founded in 2005. |
| Where is Bactiguard headquartered? | Bactiguard is headquartered in Sweden. |
| How many employees does Bactiguard have? | As of today, Bactiguard has 217 employees. |
| Who is the CEO of Bactiguard? | Bactiguard's CEO is Mr. Thomas von Koch. |
| Is Bactiguard publicy listed? | Yes, Bactiguard is a public company listed on STO. |
| What is the stock symbol of Bactiguard? | Bactiguard trades under BACTI B ticker. |
| When did Bactiguard go public? | Bactiguard went public in 2014. |
| Who are competitors of Bactiguard? | Similar companies to Bactiguard include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Bactiguard? | Bactiguard's current market cap is $111M |
| What is the current revenue of Bactiguard? | Bactiguard's last 12-month revenue is $25.8M. |
| What is the current EBITDA of Bactiguard? | Bactiguard's last 12-month EBITDA is $2.1M. |
| What is the current EV/Revenue multiple of Bactiguard? | Current revenue multiple of Bactiguard is 4.7x. |
| What is the current EV/EBITDA multiple of Bactiguard? | Current EBITDA multiple of Bactiguard is 58.8x. |
| What is the current revenue growth of Bactiguard? | Bactiguard revenue growth between 2023 and 2024 was 28%. |
| Is Bactiguard profitable? | Yes, Bactiguard is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
